Navigation Links
iSirona Announces Go-live at University Hospitals in Cleveland
Date:11/18/2009

Medical Centers Simplify Clinical Workflow Using iSirona Technology

Panama City, Fla. (PRWEB) November 18, 2009 --iSirona®, an innovative provider of data automation solutions for healthcare providers, today announced the successful "go-live" of iSirona's DeviceConX at University Hospitals Geneva Medical Center and University Hospitals Geauga Medical Center. Both facilities are part of Cleveland, Ohio-based University Hospitals and are using iSirona technology to deliver patient medical device data automatically to the Eclipsys Sunrise Electronic Medical Record.

The iSirona solution is unique in that it is patient-centric, rather than location-based, ensuring data is documented to the correct patient. In an effort to further simplify clinical workflow, University Hospitals has embedded iSirona's device association screen into Eclipsys Sunrise, giving clinicians the ability to associate a medical device to the correct patient without ever leaving the Eclipsys application.

The solution is currently automating the collection of GE patient monitor data, with future plans to collect data from Spacelabs, Philips and HP across 10 University Hospitals facilities.

"The University Hospitals system was in the process of rolling out Eclipsys for nurse documentation, and we recognized rather quickly that we needed to automate the collection of patient data from medical devices to realize the full value of electronic nurse documentation," explains John Hendricks, technology director of electronic medical records at University Hospitals. "Thanks to iSirona, now we can look forward to enhancing clinical workflow and integrating patient data from a wide range of device manufacturers."

"University Hospitals is a forward-thinking and prestigious hospital enterprise that sees the value of medical device data integration and its abili
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. iSirona Selects New Chairman of the Board
2. Oncolytics Biotech(R) Inc. Announces Unit Offering
3. Vivakor, Inc. Announces Stock Dividend
4. Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
5. Senesco Technologies, Inc. Announces Management Change
6. Arts Way Manufacturing Announces Contract for Modular Swine Facility for the University of Georgia
7. Neogen Announces 3 for-2 Stock Split
8. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
9. SemBioSys announces third quarter 2009 financial and operational results
10. 3SBio Inc. Announces Unaudited Third Quarter 2009 Results
11. PDL BioPharma Announces Special Dividend Payment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
(Date:9/17/2014)... - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a ... and products for advanced microarray diagnostics, today announced that ... the United States on the ... September 17, 2014 on the OTCQX under the symbol ... TSX Venture Exchange under its existing symbol SQD. ...
(Date:9/17/2014)... California , 17 de septiembre de ... ("la compañía"), principal proveedor mundial de soluciones ... las ciencias de la vida, anunció hoy ... de logística global con sede en Rótterdam, ... base de clientes Europa en rápido crecimiento. ...
(Date:9/17/2014)... , September 17, 2014 ... of action from a truly novel class ... MGB Biopharma, a biopharmaceutical company developing ... today that it has secured £4.0m ($6.4m) ... antibacterial, MGB-BP-3, against a range of Gram-positive ...
Breaking Biology Technology:Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7
... Belgium, May 14 , - ... Accordance With the Law of May 2, 2007 , ... company,focused on the discovery and development of innovative treatments for ... update for,the three month period ending 31 March, 2009. , ...
... the quarter increase 4.2% vs. prior year -DENVER, May 14 ... developer and marketer of diagnostic test kits, today filed its ... disclosed that the company,s sales have increased during the quarter ... prior year. Some of the results highlighted by the report ...
... Phase 2 Program Combines Histology, Biomarkers and Non-Invasive Imaging ... Vascular InflammationSAN FRANCISCO, May 14 VIA ... company focused on the development of compounds for the ... it has completed enrollment in a Phase 2 clinical ...
Cached Biology Technology:ThromboGenics NV: Business Update 2ThromboGenics NV: Business Update 3ThromboGenics NV: Business Update 4ThromboGenics NV: Business Update 5ThromboGenics NV: Business Update 6ThromboGenics NV: Business Update 7Corgenix Reports Third Quarter Fiscal 2009 Financial Results 2Corgenix Reports Third Quarter Fiscal 2009 Financial Results 3Corgenix Reports Third Quarter Fiscal 2009 Financial Results 4VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 2VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 3VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 4VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients 5
(Date:9/16/2014)... species has its own bacterial identity. That,s the conclusion ... institutions who studied the genetic fingerprints of bacteria on ... , "This study demonstrates for the first time that ... ecological strategies possess very different microbial communities on their ... postdoctoral researcher in the UO,s Institute of Ecology and ...
(Date:9/16/2014)... diameter chunk of rock hit the Yukatan peninsula near the ... of 100 teratons of TNT. It left a crater more ... earthquakes and volcanism are widely accepted to have wiped out ... mammals. But what happened to the plants on which the ... the University of Arizona reveals that the meteorite impact that ...
(Date:9/16/2014)... between viruses, bacteria, and their environment is becoming ... between Matthew Sullivan, associate professor in the University ... and Steven Hallam from the University of British ... drivers of nutrient and energy cycles that power ... changing, so are the environments these bacteria live ...
Breaking Biology News(10 mins):Microbiome research shows each tree species has a unique bacterial identity 2Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3New research decodes virus-host interactions in ocean dead zones 2New research decodes virus-host interactions in ocean dead zones 3
... phenomenon that occurs in biological systems ranging from ... across thousands of kilometers. , The National ... now accepting applications for its Investigative Workshop: Synchrony ... April 11-13, 2011, at NIMBioS on the University ...
... a world first, a new ,state of the art, ... University of Queensland,s Heron Island Research Station. ... Professor Sophie Dove and Dr. David Kline from the ... of the largest and most accurately controlled ocean acidification ...
... single-cell organisms that affect oral health, Millicent "Mimi" Goldschmidt, ... The University of Texas Health Science Center at Houston ... Society for Microbiology (ASM) Founders Distinguished Service Award. ... to the society. Goldschmidt joined the ASM in 1949 ...
Cached Biology News:Conditioning reefs for the future 2UTHealth professor to receive service award from American Society for Microbiology 2
... a simple high performance method for removing ... without significant dilution of protein solution. ... Detergent-OUT Spin column and collect detergent free ... removing detergent from a maximum of 0.2 ...
... Chemicon Detergent-OUT SDS Kit is a simple ... protein solutions. Removes detergents without significant ... the protein solution on the Detergent-OUT Spin ... Med columns are suitable for removing ...
... from frozen embedded tissue blocks, which are ... ensure the highest quality. Tissues of each ... sectioned at a thickness of 7 microns ... large (3-5 mm in diameter) in comparison ...
... Zyagen tissue microarrays are derived from frozen ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... coated slides. Sections are large (3-5mm in ...
Biology Products: